Satsuma Pharmaceuticals, Inc. Debt Conversion, Converted Instrument, Amount
Satsuma Pharmaceuticals, Inc. reported Debt Conversion, Converted Instrument, Amount of $73.14 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2020-11-10
- Satsuma Pharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2018-12-31 was $0.00.
- Satsuma Pharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2018 was $134.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|
| 2019-09-30 | $73.14M 10-Q · filed 2020-11-10 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $134.00K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $134.00K 10-Q · filed 2019-11-12 |